http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113244239-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate | 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113244239-B |
| titleOfInvention | Application of linagliptin in preparation of medicine for relieving intestinal toxicity caused by chemotherapy |
| abstract | The invention discloses application of linagliptin in preparing a medicament for relieving intestinal toxicity caused by chemotherapy. The invention discovers that linagliptin can remarkably reduce the weight reduction of a rat induced by a chemotherapeutic drug irinotecan, remarkably relieve rat diarrhea and intestinal injury caused by irinotecan, remarkably improve the barrier function of the intestinal tract of the rat and remarkably relieve the intestinal toxicity caused by irinotecan. Therefore, in the tumor chemotherapy process, the traditional Chinese medicine composition can be combined with linagliptin to intervene and relieve intestinal toxicity caused by clinical chemotherapy. |
| priorityDate | 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.